Novartis has completed construction of a new 1MW solar unit near its Vacaville biopharmaceutical site in California. The five acre array will supply 20 per cent of the manufacturing facility's electrical needs.
In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.
Find out who else is a subscriber »
Become a Premium SubscriberIf you are already a NewNet subscriber please log in below.
Legals & Terms of Use • Privacy Policy
NewNet is a trading name of New Energy World Network Ltd, registered in England (No. 06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © New Energy World Network (NewNet) 2008-2012